Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold" refers to a surgical technology used to repair focal defects in articular cartilage, especially of the knee. In this procedure, a patient’s own cartilage cells (chondrocytes) are harvested, expanded in vitro, and implanted into the cartilage defect, often using a biocompatible scaffold to enhance cell retention and support cartilage regeneration. There are several generations of this technique, including matrix-induced autologous chondrocyte implantation (MACI), which uses a collagen or synthetic matrix to deliver the cells. The primary goal is to generate new hyaline-like cartilage to restore function and decrease symptoms in people with isolated cartilage injuries[1][3][6][9]. While not a molecular target itself, the procedure acts on cartilage through biological repair and cellular proliferation.
Surgical delivery of expanded autologous chondrocytes to cartilage defects Support of cell attachment/growth by biocompatible scaffold Promotion of hyaline-like or fibrocartilage regeneration[1][6][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage regeneration via autologous chondrocyte implantation on biocompatible scaffold.